🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 2000.0mg (63 products)
Median 2000.0mg This product: 500mg

Label Claims — Verification

All Other
All Other (97% of products) Structure/Function (94% of products) Nutrient (48% of products) No Claim (2% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, adults take 1 capsule daily or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Tamper resistant package, do not use if outer seal is missing.

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #7432 / #97438

Product Details

DSLD Entry Date 2012-06-01
Product Type Amino acid/Protein
Form Capsule
DSLD ID 8698
Data Updated 2026-04-11

Research Evidence

9 Research Sources
37 Avg Quality Score
5 Rct
4 Other
C The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia
Rct Nutrients 2023
C Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Rct Journal of psychopharmacology (Oxford, England) 2012
C The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial
Rct PloS one 2017
C Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers
Rct International journal of sport nutrition and exercise metabolism 2019
C Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis
Other Neuroscience letters 2021
D A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain
Rct Anesthesia and analgesia 2004
D The efficacy of adrenocorticotropic hormone in a girl with anti-N-methyl-D-aspartate receptor encephalitis
Other Brain & development 2018
D The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats
Other Reproductive biology and endocrinology : RB&E 2009
F Blockage of N-methyl-D-aspartate receptors decreases testosterone levels and enhances postnatal neuronal apoptosis in the preoptic area of male rats
Other Neuroendocrinology 2000
View all evidence for D Aspartic Acid →

Compare Similar Products

View all D Aspartic Acid products →